Pharma's Almanac TV
PA TV
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Follow the Journey
Companies On The Road
Arcadis DPS Group
C2 Pharma
CAI
EcoLab
Environmental Systems Corporation
Federal Equipment Company
Globyz Biopharma Services
Grifols
Integrity
Nu-Tek BioSciences
PHARMALEX
Waters Corporation
Follow the Completed Journey
Companies On The Road
Follow The Artist
ABS
aCGT Vector
Alconox Inc.
Andelyn Biosciences
Arranta Bio
Avid Bioservices
BDD
BIOVECTRA
DPS Group
Dynamk Capital
Environmental Systems Corporation
Federal Equipment Company
Genesis AEC
Globyz Biopharma Services
Grifols Partnership
IDT Biologika
Inceptor Bio
IPS-Integrated Project Services
Kineticos Life Sciences
MilliporeSigma
Montana BioScience Alliance
Olon
Rentschler Biopharma
SanaClis
Scorpion Biological Services
Secant Group
Tapemark
VITRONIC
Follow the Completed Journey
Companies We've Met
AES Clean Technology
Altis Biosystems
Arranta Bio
Avara Pharmaceutical Services
Avid Bioservices
BioVectra
Centaur BPS
Dynamk Capital
ECRI
Evolve Biologics
Federal Equipment Company
Globyz
Inceptor Bio
IPS-Integrated Project Services
Olon
Pii
Polpharma Biologics
PPD
RoosterBio
SanaClis
Sanofi AIS
SGD Pharma
SPI Pharma
TriRx Pharmaceutical Services
Yourway
Dashboard
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Magazine
Archive
Reports
2021 Cell & Gene Therapy Report
2021 Monoclonal Antibody & Recombinant Protein Market Report
2022 Sterile Drug Market Report
2022 API Market Report
2022 OSD Market Report
Community
Company A to Z
Follow the Journey
Companies On The Road
Follow The Artist
Follow the Journey
Companies On The Road
More+
Staffing
Media Kit
Lonza
29 Articles Available
1
2
Can't find what you're looking for? Try our
advanced search
.
International Markets
In what international markets do you anticipate significant developments in the near future?
PAO-01-23-RT-02
Disruptive Technology
What do you view as the most disruptive or transformational technology or development on the horizon?
PAO-01-23-RT-01
Unmet Needs
In which orphan spaces or unmet medical needs do you think we will see the next treatment innovations?
PAO-06-022--RT-01
Industry Challenges
What do you consider the biggest challenge that the pharma/biopharma industry currently faces?
O-06-022--RT-01
Immuno-Oncology
Tuning the Myeloid Compartment with a Best-in-Class CDMO
PAO-06-022-CL-04
Leadership
Q: What’s the key to being a leader in the industry?
PAO-03-022-RT-02
Milestones
Q: What important company milestone do you anticipate reaching in 2022?
PAO-03-022-RT-01
Automation
Innovating in Automation and Data Management to Advance Microbiology
PAO-03-22-R250-06
Drug Development
Advancing Drug Development with Emerging Technologies
PAO-02-22-R250-03
Personalized and Precision Medicine
Q: What do you see as the key innovations or technologies that will make personalized/precision medicine a reality?
PAO-12-21-RT-01
Therapeutic Progress
Q: For what therapeutic area do you think we will see the greatest progress in the coming years?
PAO-12-21-RT-02
Bispecific Antibodies
A Small Biotech with Two Complex Bispecific Antibody Candidates Benefits from Lonza’s Blend of Expertise and Flexibility
PAO-12-21-CL-01
Biotech-CDMO Relationship
For mAbs, a Small Biotech Recognizes the Value in Lonza’s Expertise and Track Record
PAO-09-21-CL-03
Biotech-CDMO Relationship
Illustrating a Successful Small Biotech-CDMO Relationship
PAO-08-21-CL-03
Vaccine Collaboration
Moderna and Lonza Announce Worldwide Strategic Collaboration to Manufacture Moderna’s Vaccine Against Novel Coronavirus
PR-M05-20-NI-001
3D Bioprinting
Lonza and Allevi Collaborate to Advance 3D Bioprinting
PR-M01-20-NI-012
Bispecific Antibody
Challenges of Manufacturing the Expanding Range of Bi/Multispecific Modalities
PAP-Q4-19-CL-022
Agreement
Cellectis and Lonza Enter cGMP Manufacturing Service Agreement for Cellectis’ Allogeneic UCART Product Candidates
PR-M10-19-NI-006
Partnership
Lonza Partners with Vineti Across its Cell and Gene Therapy Manufacturing Network to Optimize 'Vein-to-Vein' Delivery Service
PR-M08-19-NI-008
Growth
Lonza on Track to Deliver Full-Year 2019 Results, Driven by Pharma Biotech Business
PR-M07-19-NI-069
Acquisition
Lonza Will Purchase a Sterile Fill-Finish Site from Novartis
PAO-M07-19-NI-012
M&A
Lonza to Acquire Sterile Fill and Finish Facility from Novartis
PR-M07-19-NI-010
Partnership
Alector Opts for Lonza’s Ibex™ Develop to Secure Future Manufacturing for Neurodegeneration Therapies
PR-M05-19-NI-032
DCAT '19
Highly Potent API and Sterile Capabilities Key to DCAT Week ‘19 Company Announcements
PAO-M03-19-NI-024
1
2
»
